The endocrine test is used to measure functioning of endocrine gland by checking hormone levels in the body. Endocrine system includes glands in body which make hormones. These hormones play an important role in making sure body works. Endocrine test detects any imbalances in hormonal levels in an individual’s body.
High prevalence rate of chronic diseases, and increasing incidence of endocrine disorders are factors expected to drive growth of the global endocrine testing market over the next five years
Increasing incidence of endocrine disorders such as diabetes, infertility, thyroid disorders, etc. and high prevalence rate of obesity are key factors driving growth of the global endocrine testing market. In addition, rising demand for consumption of high-sugar foods and technological advancements in endocrine testing equipment in terms of accuracy are other major factors expected to boost growth of the global endocrine testing market over the forecast period.
However, high cost of endocrine equipment and testing is a key factor restraining growth of the global endocrine testing market. Additionally, limited awareness about endocrine testing and high operational costs are other major factors expected to hamper growth of the global endocrine testing market over the forecast period.
Developments in endocrine testing such as in liquid chromatography-mass spectrometry (LC-MS) is expected to provide opportunities for players in the market to expand their presence over the forecast period. Also, increasing incidences of endocrine disorders and growing awareness about healthcare in emerging economies are expected to boost demand of endocrine testing to a significant extent.
The global endocrine testing market segmented on the basis of test type, technology, end-use, and region. On the basis of region, the global endocrine testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Do Inquiry About Report Here: https://marketresearch.biz/report/endocrine-test-market/#inquiry
Currently, the market in North America dominates the global endocrine testing market in revenue terms owing to presence of well-developed hospitals, government funding for better healthcare services, and increasing health awareness among individuals in countries in the region. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing number of patients suffering from endocrine disorders, and growing government initiatives for improvement of healthcare facilities in countries in the region.
Prominent players in the global endocrine testing market include Abbott Laboratories, AB Sciex LLC., Agilent Technologies, Inc., Biomedical Technologies Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, and Siemens AG.